gathered data from the STEP (Semaglutide Treatment Effect in People with Obesity), SUSTAIN (Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes), and PIONEER (Peptide Innovation for Early Diabetes Treatment) trials on semaglutide and weight loss
Regulatory agencies have not issued warnings linking these medications to dementia or Alzheimers disease, and the current body of evidence does not establish that they increase cognitive risk
p53 tumour-suppressor caution Because FOXO4-DRI intervenes in the p53 pathway, which is critical for tumour suppression, there is theoretical concern that interfering with p53 dynamics might carry oncogenic risk
Browse all Peptides & GLP-1 education If you are trying to figure out whether you can use HRA, FSA, or HSA dollars for a GLP-1 medication like Wegovy, Zepbound, Ozempic, or Mounjaro, the short answer is the same one your benefits administrator will give you: it depends on your plan
GPX4 inhibition with RSL3 induces ferroptosis, lipid peroxidation and reactive oxygen species (ROS) in thyroid cancer cells in vitro We targeted the ferroptosis pathway in PTC cells in vitro using a pharmacologic inhibitor of GPX4, RSL3